Vantage Awarded 'Most Reliable Trading Experience Australia 2025' at World Business Outlook Awards

Vantage Awarded 'Most Reliable Trading Experience Australia 2025' at World Business Outlook Awards

Vantage Markets is proud to announce that it has been awarded 'Most Reliable Trading Experience Australia 2025' at the World Business Outlook Awards. This recognition reinforces Vantage's commitment to providing Australian traders with a secure, transparent, and seamless trading environment, supported by cutting-edge technology and client-focused services.
Fujitsu and QuTech realize high-precision quantum gates

Fujitsu and QuTech realize high-precision quantum gates

Fujitsu Limited today announced the world's first demonstration of a complete universal quantum gate set for diamond spin qubits with an error probability below 0.1%, achieving a fidelity among the highest reported over all quantum hardware technologies.
Endless Announces Partnership with University of Surrey, Accelerating Web3 and AI Innovations

Endless Announces Partnership with University of Surrey, Accelerating Web3 and AI Innovations

Endless is thrilled to reveal its new partnership with the University of Surrey , marking a significant step forward for the Endless ecosystem.
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025.
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 for Platinum-resistant Ovarian Cancer

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 for Platinum-resistant Ovarian Cancer

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed with IBI354 in a randomized, controlled, multicenter Phase 3 clinical trial, for platinum-resistant ovarian cancer with HER2 expression.
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

Clover Biopharmaceuticals, Ltd.today announced IND clearance by U.S. FDA and that enrollment of the first participants has been completed in a Phase I revaccination clinical trial evaluating SCB-1019
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

Everest Medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for EVM14, a Tumor-Associated Antigen (TAA) vaccine.
Confidence among small businesses in Singapore rises

Confidence among small businesses in Singapore rises

Business sentiment among small businesses in Singapore last year surged to its highest level since 2019, and this positive trend is expected to continue into 2025, according to the latest survey by global professional accounting body CPA Australia.
Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence

Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence

Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones:
Hyundai Capital Australia Obtains Its First Credit Rating of 'A-' from S&P Global Ratings

Hyundai Capital Australia Obtains Its First Credit Rating of 'A-' from S&P Global Ratings

Hyundai Capital Services announced today that its 12th financial subsidiary, Hyundai Capital Australia Pty. Ltd., obtained its inaugural credit rating of 'A-' with a stable outlook from S&P Global Ratings ("S&P").
Making AI inclusive engine for global development

Making AI inclusive engine for global development

China's AI model DeepSeek has gained global attention, reigniting discussions on inclusive AI development and improving access to AI services.
AWE 2025: MOVA Sparks New Wave in Smart Home Technology with Ultimate Innovation

AWE 2025: MOVA Sparks New Wave in Smart Home Technology with Ultimate Innovation

On March 23rd , AWE 2025 officially concluded. At this grand gathering of global technology and innovation, the high-end smart home appliance brand MOVA made a stunning appearance with twelve pioneering technologies and a full range of new products.
Dreame Technology Launches Whole-House Smart Ecosystem at AWE2025, Redefining the Future of Home Living

Dreame Technology Launches Whole-House Smart Ecosystem at AWE2025, Redefining the Future of Home Living

The four-day Appliances & Electronics World Expo 2025 (AWE2025) concluded at the Shanghai New International Expo Center.
|< < 1 2 3 4 > >|